超声引导下髂腰肌腱周皮质类固醇注射的短期疗效
前瞻性研究纳入178例12至50岁髂腰肌腱病患者,注射前及注射后6周完成髋关节功能障碍与骨关节炎结局评分(HOOS)问卷,比较伴与不伴髋关节腔内异常者的评分变化。结果显示所有HOOS亚类均有时间效应,无髋关节腔内异常者在运动娱乐功能和生活质量评分上改善更明显;作者认为超声引导下注射可改善短期结局,无论是否合并髋关节腔内异常。
要点
- 超声引导下髂腰肌腱周皮质类固醇注射后6周,伴与不伴髋关节腔内异常者的HOOS各亚类评分均随时间改善。
- 无髋关节腔内异常者运动娱乐功能评分改善优于有异常者(P=.032;η2=0.056)。
- 无髋关节腔内异常者生活质量评分改善优于有异常者(P=.001;η2=0.135)。
核心结论
- 在髂腰肌腱病患者中,超声引导下髂腰肌皮质类固醇注射可改善结局,无论是否合并髋关节腔内异常;无髋关节腔内异常者在运动娱乐功能和生活质量评分上改善更明显。
研究设计与样本
- 前瞻性研究,纳入178例(女154例、男24例)12至50岁髂腰肌腱病患者,注射前及注射后6周完成HOOS问卷,采用双因素重复测量协方差分析(效应量η2)比较正常髋与伴髋关节腔内异常的异常髋。
诊断标准与关键数值
- 主要结局为HOOS各亚类评分变化;时间效应:症状P=.041、η2=0.050,疼痛P=.001、η2=0.184,日常生活活动P=.011、η2=0.076,运动娱乐功能P=.001、η2=0.151,生活质量P=.001、η2=0.193;正常髋与异常髋差异:运动娱乐功能P=.032、η2=0.056,生活质量P=.001、η2=0.135。
临床应用与阅片要点
- 作者认为,超声引导下髂腰肌注射治疗髂腰肌腱病可能促进短期照护并有助于继续非手术治疗方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Treatment for iliopsoas tendinopathy includes ultrasound (US)-guided iliopsoas peritendinous corticosteroid injection. Evidence is lacking regarding US-guided iliopsoas injection efficacy in patients with iliopsoas tendinopathy and intra-articular (IA) hip abnormalities. The purpose of this study was to examine the efficacy of US-guided iliopsoas corticosteroid injection for iliopsoas tendinopathy in patients with and without IA hip abnormalities.
METHODS: This work was a prospective study evaluating patients aged 12 to 50 years with iliopsoas tendinopathy. Participants completed a Hip Disability and Osteoarthritis Outcome Score (HOOS) questionnaire before and 6 weeks after injection. The main outcome measure was the change in HOOS subcategory scores. Independent variables included time and hip status. Normal hips were compared to abnormal hips with IA abnormalities. A 2-way repeated measures analysis of covariance with effect size (η2 ) was used to determine injection effects on HOOS scores before and 6 weeks after injection.
RESULTS: A total of 178 patients (154 female and 24 male) were analyzed. Time effects were found for both normal and abnormal hips in all HOOS subcategories: symptoms (P = .041; η2 = 0.050), pain (P = .001; η2 = 0.184), activities of daily living (P = .011; η2 = 0.076), function in sports and recreation (P = .001; η2 = 0.151), and quality of life (QOL; P = .001; η2 = 0.193). Significant differences between normal versus abnormal hips were found in the sports and recreation (P = .032; η2 = 0.056) and QOL scores (P = .001; η2 = 0.135).
CONCLUSIONS: In patients with iliopsoas tendinopathy, US-guided iliopsoas corticosteroid injection improved outcomes regardless of coexisting IA hip abnormalities. Patients without IA hip abnormalities showed greater improvement in sports and recreation and QOL scores compared to patients with IA hip abnormalities. Ultrasound-guided iliopsoas injection for iliopsoas tendinopathy may advance short-term care and help continue with nonsurgical treatment regimens.
引用
- Han JS, Sugimoto D, McKee-Proctor MH, et al. Short-term Effect of Ultrasound-Guided Iliopsoas Peritendinous Corticosteroid Injection. J Ultrasound Med. 2018. PMID: 30380165. doi:10.1002/jum.14841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。